secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2022-07-20T23:59:59+00:00
Accession:  0001607062-22-000464
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma issues 54.5M shares to retire $180,552 convertible note with Coventry
--------------------------------------------------------------------------------

- Issued 54,514,492 common shares to Coventry Enterprises LLC to satisfy $180,552 of convertible indebtedness.
- Principal and accrued interest on $1.5M promissory note now $0 as of July 19, 2022.
- Shares issued under Section 4(a)(2) exemption; no underwriter or commission paid.
- Significant dilution for existing shareholders; all outstanding convertible debt now retired.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706222000464/0001607062-22-000464-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706222000464/rgbp072022form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-22-000464

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer